Association Between Chlorthalidone Treatment of Systolic Hypertension and Long-term Survival

In the SHEP trial, treatment of isolated systolic hypertension with chlorthalidone stepped-care therapy for 4.5 years was associated with longer life expectancy at 22 years of follow-up.